Olsen A, Siboska GE, Clark BF, Rattan SI. N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 1999;265:499-502.
Bruneton J. Pharmacognosy Phytochemistry Medicinal Plants. 2nd ed. Paris, FR: Lavoisier, 1999:142.
Rattan SI, Clark BF. Kinetin delays onset of aging characteristics in human fibroblasts. Biochem Biophys Res Commun 1994;201:665-72.
Barciszewski, J., Mielcarek, M., Stobiecki, M., Siboska, G., and Clark, B. F. Identification of 6-furfuryladenine (kinetin) in human urine. Biochem Biophys Res Commun. 12-9-2000;279(1):69-73.
Hsiao, G., Shen, M. Y., Lin, K. H., Chou, C. Y., Tzu, N. H., Lin, C. H., Chou, D. S., Chen, T. F., and Sheu, J. R. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo. Eur J Pharmacol 4-4-2003;465(3):281-287.
Adunka, O., Moustaklis, E., Weber, A., May, A., von Ilberg, C., Gstoettner, W., and Kierner, A. C. Labyrinth anesthesia--a forgotten but practical treatment option in Meniere's disease. ORL J Otorhinolaryngol.Relat Spec. 2003;65(2):84-90.
Sheu, J. R., Hsiao, G., Shen, M. Y., Chou, C. Y., Lin, C. H., Chen, T. F., and Chou, D. S. Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation. Platelets. 2003;14(3):189-196.
Griffaut, B., Bos, R., Maurizis, J. C., Madelmont, J. C., and Ledoigt, G. Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells. Int J Biol Macromol. 2004;34(4):271-275.
Hessemer, V., Hoppe, O., and Jacobi, K. W. [Effect of hyaluronidase on ocular circulatory changes caused by retrobulbar anesthesia]. Fortschr Ophthalmol. 1991;88(2):196-200.
Krohn, J., Seland, J. H., Hovding, G., Bertelsen, T., Aasved, H., and Haugen, O. H. Retrobulbar anesthesia with and without hyaluronidase in extracapsular cataract surgery. A prospective, randomized, double-blind study. Acta Ophthalmol.(Copenh) 1993;71(6):791-795.
Barciszewski, J., Siboska, G. E., Pedersen, B. O., Clark, B. F., and Rattan, S. I. Evidence for the presence of kinetin in DNA and cell extracts. FEBS Lett 9-16-1996;393(2-3):197-200.
Baum C, Bohnen S, Sill B, et al. Prolonged resuscitation and cardiogenic shock after intoxication with European yew (Taxus baccata): Complete recovery after intermittent mechanical circulatory support. Int J Cardiol. 2015;181:176-8.
Orr AL, Rutaganira FU, de Roulet D, et al. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease. Neurochem Int. 2017;109:106-116.
Jablońska-Trypuć A, Matejczyk M, Czerpak R. N6-benzyladenine and kinetin influence antioxidative stress parameters in human skin fibroblasts. Mol Cell Biochem. 2016;413(1-2):97-107.
Wanitphakdeedecha R, Meeprathom W, Manuskiatti W. Efficacy and safety of 0.1% kinetin cream in the treatment of photoaging skin. Indian J Dermatol Venereol Leprol. 2015;81(5):547.
Pros E, Fernández-Rodríguez J, Benito L, et al. Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment. Eur J Hum Genet. 2010;18(5):614-7.
Gold-von Simson G, Goldberg JD, Rolnitzky LM, et al. Kinetin in familial dysautonomia carriers:
implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res. 2009;65(3):341-6.
Berge U, Kristensen P, Rattan SIS. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci. 2006;1067:332-6.
Dudzik P, Dulińska-Litewka J, Wyszko E, et al. Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines. J Cell Biochem. 2011;112(8):2115-24.
Chiu PC, Chan CC, Lin HM, Chiu HC. The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol. 2007;6(4):243-9.
Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol. 2007;32(6):693-5.